Agency Forms Undergoing Paperwork Reduction Act Review, 58485-58486 [2015-24681]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 188 / Tuesday, September 29, 2015 / Notices
assistance applications for conformity to
laws, regulations, policies, and
alignment to CDC’s public health goals;
(6) issues grants and cooperative
agreements; (7) provides continuing
surveillance of financial and
administrative aspects of assistancesupported activities to ensure
compliance with HHS and CDC policies;
(8) ensures that grantee performance is
in accordance with assistance
requirements; (9) collects and reports
business management and public health
programmatic data, analyzes and
monitor business management data on
grants and cooperative agreements and
maintains assistance files; and (10)
provides innovative problem-solving
methods in the coordination of
international grants for a wide range of
public health partners in virtually all
major domestic and international health
organizations including resolving issues
with the Department of State.
Delete in its entirety the mission and
function statements for the Procurement
and Grants Office (CAJH).
James Seligman,
Acting Chief Operating Officer, Centers for
Disease Control and Prevention.
John Jernigan, MD, MS,
Division of Healthcare Quality
Promotion, National Center for
Emerging and Zoonotic Infectious
Diseases, Centers for Disease Control
and Prevention, 1600 Clifton RD,
Atlanta, GA 30333. Phone: 404–639–
4245. FAX: 404–639–4046. Email: jqj9@
cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Deborah Loveys, Ph.D., Extramural
Programs Research Office, National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention, Centers for
Disease Control and Prevention, U.S.
Department of Health and Human
Services, 1600 Clifton Road, MS E–60,
Atlanta, GA 30333. Telephone: (404)
718–8834. Fax: (404) 718–8848. Email:
hft6@cdc.gov.
ADDRESSES:
Dated: September 22, 2015.
Tiffanee Woodard,
Deputy Branch Chief, Epidemiology Research
and Innovations Branch, Division of
Healthcare Quality Promotion, Centers for
Disease Control and Prevention.
Terrance Perry,
Director, Office of Grants Services, Centers
for Disease Control and Prevention.
[FR Doc. 2015–24673 Filed 9–28–15; 8:45 am]
[FR Doc. 2015–24601 Filed 9–28–15; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
[30Day–15–0728]
Epi-Centers for the Prevention of
Healthcare-Associated Infections,
Antimicrobial Resistance and Adverse
Events
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (DHHS).
ACTION: Notice of Domestic Single
Source Competition Expansion
Supplement Funding Opportunity
Announcement (FOA).
AGENCY:
The National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID) will be providing a
Single Source Competition Supplement
to Harvard Pilgrim Healthcare, an
awardee of the Epi-Centers for the
Prevention of Healthcare-Associated
Infections, Antimicrobial Resistance and
Adverse Events Cooperative Agreement.
The single source supplement will fund
research utilizing proprietary methods
to improve sepsis prevention by better
defining the burden, preventability and
identifying measurers to track progress.
DATES: Effective date is date of
publication in the Federal Register.
asabaliauskas on DSK5VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:54 Sep 28, 2015
Jkt 235001
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies’ estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
58485
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
National Notifiable Diseases
Surveillance System—Revision—Center
for Surveillance, Epidemiology and
Laboratory Services (CSELS), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Public Health Services Act (42
U.S.C. 241) authorizes CDC to
disseminate nationally notifiable
condition information. The Nationally
Notifiable Diseases Surveillance System
(NNDSS) is based on data collected at
the state, territorial and local levels as
a result of legislation and regulations in
those jurisdictions that require health
care providers, medical laboratories,
and other entities to submit healthrelated data on reportable conditions to
public health departments. These
reportable conditions, which include
infectious and non-infectious diseases,
vary by jurisdiction depending upon
each jurisdiction’s health priorities and
needs. Infectious disease agents and
environmental hazards often cross
geographical boundaries. Each year, the
Council of State and Territorial Disease
Epidemiologists (CSTE), supported by
CDC, determines which reportable
conditions should be designated
nationally notifiable and voluntarily
submitted to CDC so that information
can be shared across jurisdictional
boundaries and both surveillance and
prevention and control activities can be
coordinated at regional and national
levels.
CDC requests a three-year approval for
a Revision for the National Notifiable
Diseases Surveillance System (NNDSS),
(OMB Control No. 0920–0728,
E:\FR\FM\29SEN1.SGM
29SEN1
58486
Federal Register / Vol. 80, No. 188 / Tuesday, September 29, 2015 / Notices
Expiration Date 01/31/2017). This
Revision includes new requests for
approval to: (1) Replace ‘‘Hepatitis C
virus, past or present’’ and ‘‘Hepatitis C,
acute’’ with ‘‘Hepatitis C’’ on the List of
Nationally Notifiable Conditions, (2)
replace all listed Arboviral conditions
with an inclusive category, ‘‘Arboviral
Diseases’’ on the List of Nationally
Notifiable Conditions, (3) receive case
notification data for Hantavirus
infection, non-Hantavirus Pulmonary
Syndrome, (4) receive case notification
data for Acute Flaccid Myelitis should
it become nationally notifiable, (5)
receive case notification data for
Amebic Encephalitis should it become
nationally notifiable, (6) receive new
laboratory and vaccine data elements for
all conditions, and (7) receive new
disease-specific data elements for
Mumps, Pertussis, Varicella, Arboviral
Diseases, and Sexually Transmitted
Diseases (STD).
Although this Revision includes case
notifications that were not part of the
last NNDSS Revision, the estimate of the
average burden per response based on
the burden tables from all of the
consolidated applications has not
Estimated Annualized Burden Hours
Number of
respondents
Type of respondents
Form name
States ..............................................................
Territories ........................................................
Cities ...............................................................
Weekly and Annual ........................................
Weekly and Annual ........................................
Weekly and Annual ........................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–24681 Filed 9–28–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
GH15–002: Conducting Public Health
Research in Georgia, and GH16–002:
Impact Evaluation of Combination HIV
Prevention Intervention in Botswana
under PEPFAR.
TIME AND DATE: 9:30a.m.–1:30p.m., EST,
November 4, 2015 (Closed).
PLACE: Teleconference.
STATUS: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
VerDate Sep<11>2014
17:54 Sep 28, 2015
Jkt 235001
The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
GH15–002: Conducting Public Health
Research in Georgia, and GH16–002:
Impact Evaluation of Combination HIV
Prevention Intervention in Botswana
under PEPFAR.
MATTERS FOR DISCUSSION:
CONTACT PERSON FOR MORE INFORMATION:
Centers for Disease Control and
Prevention
asabaliauskas on DSK5VPTVN1PROD with NOTICES
changed. The burden on the states and
cities is estimated to be 10 hours per
response and the burden on the
territories is estimated to be 5 hours per
response. The addition of new vaccine,
laboratory, and disease-specific data
elements do not add any additional
burden because the states, territories,
and cities already collect those data
elements. There will be no increase in
burden for the states, territories, and
cities to send those data elements to
CDC. The estimated annual burden is
28,340 hours.
Hylan Shoob, Scientific Review Officer,
Center for Global Health (CGH) Science
Office, CGH, CDC, 1600 Clifton Road
NE., Mailstop D–69, Atlanta, Georgia
30033, Telephone: (404) 639–4796.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. 2015–24657 Filed 9–28–15; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
50
5
2
Number of
responses per
respondent
52
52
52
Fmt 4703
Sfmt 4703
10
5
10
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Performance Review Board Members
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
In this notice, the Centers for
Disease Control and Prevention (CDC)
located within the Department of Health
and Human Services (HHS) is
publishing the names of the
Performance Review Board Members
who are reviewing performance for
Fiscal Year 2015.
FOR FURTHER INFORMATION CONTACT:
Sharon O’Brien, Deputy Director,
Executive and Scientific Resources
Office, Human Resources Office, Centers
for Disease Control and Prevention,
4770 Buford Highway, Mailstop K–07,
Atlanta, Georgia 30341, Telephone (770)
488–1781.
SUPPLEMENTARY INFORMATION: Title 5,
U.S.C. Section 4314(c)(4) of the Civil
Service Reform Act of 1978, Public Law
95–454, requires that the appointment
of Performance Review Board Members
be published in the Federal Register.
The following persons will serve on the
CDC Performance Review Boards or
Panels, which will oversee the
evaluation of performance appraisals of
Senior Executive Service members for
the Fiscal Year 2015 review period:
SUMMARY:
Christine Branche, Co-Chair
Frm 00025
Avg. burden
per response
(in hrs.)
E:\FR\FM\29SEN1.SGM
29SEN1
]]>Agencies
[Federal Register Volume 80, Number 188 (Tuesday, September 29, 2015)]
[Notices]
[Pages 58485-58486]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-24681]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-15-0728]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies' estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
National Notifiable Diseases Surveillance System--Revision--Center
for Surveillance, Epidemiology and Laboratory Services (CSELS), Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
The Public Health Services Act (42 U.S.C. 241) authorizes CDC to
disseminate nationally notifiable condition information. The Nationally
Notifiable Diseases Surveillance System (NNDSS) is based on data
collected at the state, territorial and local levels as a result of
legislation and regulations in those jurisdictions that require health
care providers, medical laboratories, and other entities to submit
health-related data on reportable conditions to public health
departments. These reportable conditions, which include infectious and
non-infectious diseases, vary by jurisdiction depending upon each
jurisdiction's health priorities and needs. Infectious disease agents
and environmental hazards often cross geographical boundaries. Each
year, the Council of State and Territorial Disease Epidemiologists
(CSTE), supported by CDC, determines which reportable conditions should
be designated nationally notifiable and voluntarily submitted to CDC so
that information can be shared across jurisdictional boundaries and
both surveillance and prevention and control activities can be
coordinated at regional and national levels.
CDC requests a three-year approval for a Revision for the National
Notifiable Diseases Surveillance System (NNDSS), (OMB Control No. 0920-
0728,
[[Page 58486]]
Expiration Date 01/31/2017). This Revision includes new requests for
approval to: (1) Replace ``Hepatitis C virus, past or present'' and
``Hepatitis C, acute'' with ``Hepatitis C'' on the List of Nationally
Notifiable Conditions, (2) replace all listed Arboviral conditions with
an inclusive category, ``Arboviral Diseases'' on the List of Nationally
Notifiable Conditions, (3) receive case notification data for
Hantavirus infection, non-Hantavirus Pulmonary Syndrome, (4) receive
case notification data for Acute Flaccid Myelitis should it become
nationally notifiable, (5) receive case notification data for Amebic
Encephalitis should it become nationally notifiable, (6) receive new
laboratory and vaccine data elements for all conditions, and (7)
receive new disease-specific data elements for Mumps, Pertussis,
Varicella, Arboviral Diseases, and Sexually Transmitted Diseases (STD).
Although this Revision includes case notifications that were not
part of the last NNDSS Revision, the estimate of the average burden per
response based on the burden tables from all of the consolidated
applications has not changed. The burden on the states and cities is
estimated to be 10 hours per response and the burden on the territories
is estimated to be 5 hours per response. The addition of new vaccine,
laboratory, and disease-specific data elements do not add any
additional burden because the states, territories, and cities already
collect those data elements. There will be no increase in burden for
the states, territories, and cities to send those data elements to CDC.
The estimated annual burden is 28,340 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hrs.)
----------------------------------------------------------------------------------------------------------------
States................................ Weekly and Annual....... 50 52 10
Territories........................... Weekly and Annual....... 5 52 5
Cities................................ Weekly and Annual....... 2 52 10
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-24681 Filed 9-28-15; 8:45 am]
BILLING CODE 4163-18-P
